INTRODUCTION
Aspergillosis of the nose and paranasal sinuses comprises a spectrum of disease dependent upon the severity of the infection. Greater awareness of the disease has led to more cases being diagnosed in immunocompetent hosts. We present a case of invasive aspergillosis and discuss the pathology and treatment protocols. destroying all the bony septa and the medial wall of the orbit (Figure 1 ). The right maxillary sinus was opaque, filled with soft tissue material and exhibited bony erosion of the posterolateral wall.
A right lateral rhinotomy was performed and the mass extirpated macroscopically, but the disease extended to the cririform plate and the optic nerve.
Histological examination of the operative specimen revealed non-caseating granulomatous inflammation and multinucleate giant cells surrounding branching separate fungal hyphae with appearances consistent with Asperqillus ( Figure 2 ). The patient was commenced on the antifungal, itraconazole and monitored with CT and MRI.
DISCUSSION

CASE HISTORY
A 28-year-old Sudanese woman presented with a 2 year history of right sided proptosis and facial pain. She had undergone two previous operations to remove nasal polyps. In October 1993 her symptoms deteriorated; in addition she had developed diplopia on upward gaze.
Clinical examination revealed proptosis and a palpable mass at the inner canthus. Examination of the nose showed an enlarged right inferior turbinate. CT showed a destructive mass centred on the right ethmoid labyrinth Aspergillosis is a group of fungal diseases that can cause lesions of the skin, ears, nose, paranasal sinuses, orbit, lung, bone and meninges', Although nasal infection with Asperqillus jumiBatus was first described in 1885, many of the series described have originated from the Sudan where AspeTBi/lus ftavus is the causative organism 2 ,3. Contributory factors are the hot dry climate and the presence of Asperqillus.fiavus as a ubiquitous soil saprophyte.
The increasing interest in the pathology of this condition has led to consideration of paranasal aspergillosis as a spectrum of disease: allergic, non-invasive, invasive and fulminant". Allergic aspergillus sinusitis occurs in immunocompetent patients and is normally considered to be a benign condition''. In non-invasive disease there is a fungus ball that lies extra-mucosally and is confined to one sinus. Invasive disease is characterized by spread into local tissues with necrosis and inflammation, often presenting as a facial mass and proptosis. Fulminant invasive aspergillosis normally affects neutropenic and bone marrow transplant patients. A progressive angioinvasive process takes place with a gangrenous mucopcriosteitis which is frequently fatal", Nasal symptoms are non-specific, with mucoid or mucopurulent discharge, engorged mucosa and turbinates and nasal polyps. Sinus films may show the presence of a hyperdense fungal concretion", The advent of CT imaging can identify the presence of bony erosion. MRI scanning is considered extremely diagnostic with a markedly decreased signal intensity on T 2-weighted images of areas affected by fungal invasions.
Initial surgery is usually of a minor form as the disease is often unsuspected. If cases are not to be missed, it is essential that all sinus washings and pus are sent for fungal culture in cases of persistent or refractory sinusitis. Radical surgical clearance is required for cure of the disease and may be undertaken by a variety of approaches'', The use of adjuvant anti-fungal agents remains controversial due to the associated side effects 10. Their use is normally confined to those with invasive disease or groups of immunocompromised patients. Amphotericin Band itraconazole are often used either singly or in combination. Itraconazole is comparatively non-toxic and is effective against aspergillus11.
Repeated CT and MRI have greater accuracy than clinical examination, although this should not be neglected. In the event of recurrence, aggressive treatment by a combination of surgery and antifungal chemotherapy is required.
